Hawaii Medical Journal

Table of Contents

1. Clinical Research FDA Pushes Clinical Trial Transparency in 2026

   Hawaii Medical Journal Staff April 14, 2026

   pp. 1–8
2. Oncology Pancreatic Cancer Pill Doubles Survival in New Trial

   Hawaii Medical Journal Staff April 14, 2026

   pp. 9–13
3. Clinical Research The Future of Preconception Health: Progress and Gaps

   Hawaii Medical Journal Staff April 13, 2026

   pp. 14–19
4. Clinical Research High-Dose Influenza Vaccine Benefits: Authors' Reply

   Hawaii Medical Journal Staff April 12, 2026

   pp. 20–27
5. Public Health FDA Seeks New Powers Over Drug Ads in 2026

   Michael O'Connor April 9, 2026

   pp. 28–31
6. Clinical Research FDA Backs Domestic Drug Production to Counter China

   Keala Nakamura April 8, 2026

   pp. 32–36
7. Clinical Research FDA Delay Forces Kezar Life Sciences to Close Its Doors

   Keala Nakamura April 7, 2026

   pp. 37–42
8. Clinical Research FDA Delays Force Kezar Life Sciences to Shut Down

   Keala Nakamura April 6, 2026

   pp. 43–51
9. Public Health Trump Pushes Drug Pricing Legislation in 2026

   Hawaii Medical Journal April 1, 2026

   pp. 52–56
10. Cardiology BMJ Retracts PREVENT-TAHA8 Stem Cell Heart Failure Trial

    James Liu March 31, 2026

    pp. 57–63
11. Oncology Merck Acquires Terns Pharmaceuticals for $6.7B in 2026

    James Liu March 30, 2026

    pp. 64–71
12. Clinical Research Sarepta Therapeutics Shares Surge on Rare Disease Drug Data

    Keala Nakamura March 30, 2026

    pp. 72–77
13. Public Health Parenting Challenges in Primary Care: The GP Workforce Gap

    Michael O'Connor March 30, 2026

    pp. 78–81
14. Public Health FTC Settles With CVS Over Insulin Price Manipulation

    Robert Kim March 29, 2026

    pp. 82–90
15. Medical Technology Radiologists Can't Spot AI Deepfake X-Rays, Study Finds

    Priya Patel March 29, 2026

    pp. 91–98
16. Clinical Research Electronic Marking Systems to Prevent Medical Exam Errors

    Michael O'Connor March 29, 2026

    pp. 99–106
17. Infectious Disease Pfizer Lyme Vaccine Shows 70% Efficacy But Misses Statistical Goal

    Michael O'Connor March 28, 2026

    pp. 107–111
18. Infectious Disease Insmed's Arikayce Succeeds in Phase 3 MAC Lung Trial

    James Liu March 28, 2026

    pp. 112–120
19. Clinical Research FDA Approves Kresladi Gene Therapy for Rare LAD-1 Disease

    Robert Kim March 28, 2026

    pp. 121–125
20. Medical Technology Doctronic Raises $40M Series B to Expand AI Clinical Care

    Priya Patel March 27, 2026

    pp. 126–129